2.61

1.51% -0.04

Intelligent Bio Solutions Inc (INBS)

Panoramica Notizia Cronologia dei prezzi Financials Perché INBS Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$2.65

Aprire:

$2.66

Volume 24 ore:

6,557

Relative Volume:

0.08

Capitalizzazione di mercato:

$7.88M

Reddito:

$3.91M

Utile/perdita netta:

$-11.65M

Rapporto P/E:

-0.2118

EPS:

-12.3212

Flusso di cassa netto:

$-11.51M

1 W Prestazione:

-5.78%

1M Prestazione:

+44.20%

6M Prestazione:

-42.76%

1 anno Prestazione:

-82.24%

Intervallo 1D:

$2.57

$2.70

Intervallo di 1 settimana:

$2.57

$3.49

Portata 52W:

$1.52

$24.90

Intelligent Bio Solutions Inc Stock (INBS) Company Profile

Nome

Intelligent Bio Solutions Inc

Settore

Healthcare (1085)

Industria

Medical Devices (140)

Telefono

646-790-5756

Indirizzo

135 W 41ST ST,, NEW YORK

Dipendente

Cinguettio

Prossima data di guadagno

2026-08-21

Ultimi documenti SEC

INBS's Discussions on Twitter

Compare INBS vs ABT, SYK, MDT, BSX, EW

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
INBS Intelligent Bio Solutions Inc	2.61	8.06M	3.91M	-11.65M	-11.51M	-12.32
ABT Abbott Laboratories	116.11	198.01B	46.59B	5.41B	7.38B	3.0938
SYK Stryker Corp	330.13	130.41B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	93.28	120.48B	36.36B	4.84B	5.43B	3.7261
BSX Boston Scientific Corp	50.52	75.37B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	90.31	53.19B	6.30B	1.07B	1.09B	1.8406

Intelligent Bio Solutions Inc Borsa (INBS) Ultime notizie

Aug 20, 2026

Intelligent Bio Solutions completes clinical data collection for FDA 510(k) - scanx.trade

Aug 20, 2026

INBS Looks 0.4% Overvalued on GF Value™ - GuruFocus

Aug 20, 2026

Intelligent Bio Solutions Revenue Rises 38% to $4.2 Million in Fiscal 2026 - Moomoo

Aug 20, 2026

Aug 19, 2026

Intelligent Bio Solutions resolves all cybersecurity review items ahead of H2 2026 FDA filing - scanx.trade

Aug 19, 2026

Intelligent Bio Solutions revenue rises 38% to $4.2 million - grafa.com

Aug 19, 2026

BRIEF-Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth Of 38% Year-Over-Year, Driven By Reader Installed Base And High-Margin Cartridge Growth - Bitget

Aug 19, 2026

Form 8K Intelligent Bio Solutions Inc For: 19 August By Investing.com - Investing.com Nigeria

Aug 19, 2026

Intelligent Bio Solutions Inc. Reports Earnings Results for the Full Year Ended June 30, 2026 - marketscreener.com

Aug 19, 2026

INBS FY26 Results: Revenue up 38% to $4.2M, margin expands to 48.6% - scanx.trade

Aug 19, 2026

Intelligent Bio Solutions Revenue Jumps 38% as Gross Margin Expands 778 Basis Points - Minichart

Aug 19, 2026

Intelligent Bio Solutions | 10-K: Annual report - Moomoo

Aug 19, 2026

Intelligent Bio Solutions Reports Fiscal 2026 Revenue Up 38% to $4.22M, Gross Margin 48.63% - TradingView

Aug 19, 2026

INBS: Revenue up 38% to $4.2M, gross margin 48.63%, FDA submission on track for late 2026 - TradingView

Aug 19, 2026

INTELLIGENT BIO SOLUTIONS INC. FY 2026: Revenue $4.22M, EPS $(8.44) — 10-K Summary - TradingView

Aug 19, 2026

Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth Of 38% Year-Over-Year, Driven By Reader Installed Base And High-Margin Cartridge Growth - TradingView

Aug 19, 2026

Intelligent Bio (NASDAQ: INBS) warns on cash and survival - Stock Titan

Aug 19, 2026

Intelligent Bio Solutions grows to 502 customers as net loss widens to $12.5M - Stock Titan

Aug 19, 2026

Aug 17, 2026

Intelligent Bio Solutions (NASDAQ:INBS): Can Commercial Adoption Accelerate? - Kalkine Media

Aug 17, 2026

Intelligent Bio Solutions Shares Surge Monday: What's Driving the Action? - Benzinga

Aug 17, 2026

Intelligent Bio Solutions receives ISO 13485:2016 recertification - Investing.com

Aug 17, 2026

Intelligent Bio Solutions receives ISO 13485:2016 recertification By Investing.com - Investing.com Canada

Aug 17, 2026

Intelligent Bio Solutions Strengthens Quality Management Credentials with ISO Recertification - The Manila Times

Aug 17, 2026

A Fingerprint Drug Test Aligns With the FDA's New Regulation—What's Next? - Stock Titan

Aug 17, 2026

What Should Readers Watch in Intelligent Bio Solutions (NASDAQ:INBS) as Diagnostic Adoption Comes Into Focus? - Kalkine Media

Aug 17, 2026

Aug 15, 2026

INBS Drops 7.67% to $2.77 as Intelligent Bio Solutions Approaches Key SupportNews Sentiment - Vinanet

Aug 15, 2026

Aug 14, 2026

Intelligent Bio Solutions (INBS) gets 5.91% ownership update from Armistice Capital - Stock Titan

Aug 14, 2026

Aug 13, 2026

Intelligent Bio Solutions (INBS) Surges 15.35% to $2.93 — Testing Key Resistance at $3.08Skew Index - Vinanet

Aug 13, 2026

Aug 12, 2026

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Aug 12, 2026

Aug 11, 2026

Form 8K Intelligent Bio Solutions Inc For: 11 August By Investing.com - Investing.com Canada

Aug 11, 2026

Intelligent Bio Solutions Advances FDA Fingerprinting Drug Study - TipRanks

Aug 11, 2026

Intelligent Bio Solutions completes multi-site study, targets FDA 510(k) submission in H2 2026 - TradingView

Aug 11, 2026